The growing prevalence of chronic diseases is a major factor driving revenue growth in the natural killer (NK) cell ...

The Cambridge, England-based pharmaceutical company said Imfinzi has been approved in the EU for treatments in adults with resectable muscle-invasive bladder cancer. The approval is for the use of ...

Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy Solutions Distinguished experts Dr. Jay Skyler, Dr. Desmond Schatz, and Dr. Lawrence ...

New research from UC Davis Comprehensive Cancer Center has uncovered an evolutionary change that may explain why certain ...

The term 'Cancer' makes a person freeze the moment they hear it for the first time, and one such type of cancer is bladder cancer. While this may look scary, its timely diagnosis can help in managing ...

Multidisciplinary care, a collaborative approach where various healthcare disciplines come together, is essential for treating those with prostate cancer.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

New research from UC Davis Comprehensive Cancer Center has uncovered an evolutionary change that may explain why certain ...

Earlier diagnoses and advancements in treatment options are providing hope for patients with endometrial cancer like Yaca.

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Agonists of immune checkpoint modulators for treating autoimmune and inflammatory disorders have shown high potential in ...